AACC Spotlight: Chronic Disease Management at the Point of CareImprove the patient experience with increased compliance, decreased risk of long-term complications, and improved clinical outcomes.

When a 60-year-old patient with a 2-year history of type 2 diabetes, very high triglycerides, and pancreatitis transferred from one physician to a new one, his HbA1c levels were at 14%, well above the recommended healthy range for a diabetic patient. With a mix of patient education, regular A1c testing with on-site results, and medication changes, the patient’s HbA1c levels dropped to 7.6% over the course of a year.1


Independent clinical studies have shown that in-office HbA1c testing improves diabetes patient outcomes3, 4, 5,. Availability of results at the time of visit provides healthcare providers and educators the opportunity to have meaningful, face-to-face discussions regarding treatment options. From a convenience and scheduling standpoint, it eliminates multiple visits for pre-visit blood draws or post-testing follow-up consultations.

At our AACC booth, discover solutions for albumin-to-creatinine ratio (ACR) testing, enabling detection of kidney disease at the earliest stages and improving the patient experience by allowing treatment to begin sooner.

The Xprecia Stride™ Coagulation Analyzer for PT/INR testing optimizes the diagnostic experience by providing high usability and lab-accurate results that today’s professionals demand at the point of care.